Related references
Note: Only part of the references are listed.2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
Michael H. Le et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study
Jung Il Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Anti-TNF-α Treatment Reduces the Baseline Procoagulant Imbalance of Patients With Inflammatory Bowel Diseases
Armando Tripodi et al.
INFLAMMATORY BOWEL DISEASES (2021)
Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)
Xuerong Wen et al.
PLOS ONE (2021)
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2020)
The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study
Jung-Min Lee et al.
PLOS ONE (2020)
Association between non-alcoholic fatty liver disease and obstructive sleep apnea
Ilaria Umbro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality
Donghee Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
Carmelo Luci et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps
Amedeo Lonardo et al.
HEPATOLOGY (2019)
Body mass index reduction improves the baseline procoagulant imbalance of obese subjects
Armando Tripodi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study
Alina M. Allen et al.
JOURNAL OF HEPATOLOGY (2019)
Neutrophil Extracellular Trap Formation: Physiology, Pathology, and Pharmacology
Mithunan Ravindran et al.
BIOMOLECULES (2019)
Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease
Sneha Kothari et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Vasilios G. Athyros et al.
CURRENT VASCULAR PHARMACOLOGY (2018)
Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
Dirk J. van der Windt et al.
HEPATOLOGY (2018)
Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis
Jonathan G. Stine et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2018)
Thrombin promotes diet-induced obesity through fibrin-driven inflammation
Anna K. Kopec et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Vasilios G. Athyros et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Detection of procoagulant imbalance Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin
Armando Tripodi
THROMBOSIS AND HAEMOSTASIS (2017)
Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease
J. J. Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors
Armando Tripodi et al.
ENDOCRINE (2017)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Fatty liver is an independent predictor of early carotid atherosclerosis
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven M. Francque et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Preserved hemostatic status in patients with non-alcoholic fatty liver disease
Wilma Potze et al.
JOURNAL OF HEPATOLOGY (2016)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study
Lisa B. VanWagner et al.
ATHEROSCLEROSIS (2014)
Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis
Xiaofei Wang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Statins decrease thrombin generation in patients with hypercholesterolemia
Armando Tripodi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
Armando Tripodi et al.
JOURNAL OF HEPATOLOGY (2014)
Body mass index in childhood and adult risk of primary liver cancer
Tina Landsvig Berentzen et al.
JOURNAL OF HEPATOLOGY (2014)
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study
M. Schmidt et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Thrombin Inhibition with Dabigatran Protects against High-Fat Diet-Induced Fatty Liver Disease in Mice
Anna K. Kopec et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Circulating Nucleosomes and Neutrophil Activation as Risk Factors for Deep Vein Thrombosis
Maurits L. van Montfoort et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis
N. B. Adams et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Layli Eslami et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events
Lisa B. VanWagner et al.
HEPATOLOGY (2012)
Circulating microparticles and risk of venous thromboembolism
Paolo Bucciarelli et al.
THROMBOSIS RESEARCH (2012)
Tissue Factor-Bearing Microparticles and Thrombus Formation
Jeffrey I. Zwicker et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Gender-Specific Differences in Adipose Distribution and Adipocytokines Influence Adolescent Nonalcoholic Fatty Liver Disease
Oyekoya T. Ayonrinde et al.
HEPATOLOGY (2011)
Hypercoagulability in cirrhosis: causes and consequences
A. Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation
C. T. Ammollo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay
Armando Tripodi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease
Anna Kotronen et al.
LIVER INTERNATIONAL (2011)
Increased thrombin generation in inflammatory bowel diseases
Simone Saibeni et al.
THROMBOSIS RESEARCH (2010)
High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism
Matteo Nicola Dario Di Minno et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing
Armando Tripodi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis
Quentin M. Anstee et al.
CLINICS IN LIVER DISEASE (2009)
An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
Armando Tripodi et al.
GASTROENTEROLOGY (2009)
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
Luca Miele et al.
JOURNAL OF HEPATOLOGY (2009)
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies
Q. M. Anstee et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques
Aurelie S. Leroyer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases
N. Assy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Two-way interactions between inflammation and coagulation
M Levi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Share Paper
